Obesity has been identified as a risk factor for the development of bulimia nervosa (BN). Accordingly, we hypothesize that genotypes predisposing to obesity can be detected in patients with this eating disorder. In order to investigate this hypothesis we screened the melanocortin-4 receptor gene (MC4R) for mutations using single strand conformation analysis in 81 female inpatients treated for BN. A single patient with both extreme obesity and BN had a haplo-insufficiency mutation in the MC4R. Comparison of current and maximal body mass index (BMI) of all patients with cross-sectionally obtained BMI in the general population revealed an age appropriate distribution for current BMI and a substantially increased frequency for overweight at time of maximal BMI. Our findings suggest that overweight is a risk factor for BN in clinically ascertained patients. For the first time a genotype predisposing to obesity has been detected in an extremely obese patient with BN.
Obesity has been identified as a risk factor for the development of bulimia nervosa (BN). Accordingly, we hypothesize that genotypes predisposing to obesity can be detected in patients with this eating disorder. In order to investigate this hypothesis we screened the melanocortin-4 receptor gene (MC4R) for mutations using single strand conformation analysis in 81 female inpatients treated for BN. A single patient with both extreme obesity and BN had a haplo-insufficiency mutation in the MC4R. Comparison of current and maximal body mass index (BMI) of all patients with cross-sectionally obtained BMI in the general population revealed an age appropriate distribution for current BMI and a substantially increased frequency for overweight at time of maximal BMI. Our findings suggest that overweight is a risk factor for BN in clinically ascertained patients. For the first time a genotype predisposing to obesity has been detected in an extremely obese patient with BN. Molecular Psychiatry (2002) 7, 647-651. doi:10.1038/ sj.mp. 4001053 Mild, moderate and severe obesity have repeatedly been observed in patients with BN.
1-4 DSM-III bulimia 5 was found to be more frequent among obese patients (2%) as compared with normal weight controls (0.4%). 2 Amongst a community-based cohort of 102 females with BN, childhood and parental obesity were reported as 40% and 34%, respectively, which exceeded the respective rates in healthy (11%, 11%) and psychiatric controls (15%, 20%). Because the BMI distribution of BN patients has not been assessed using population based centiles, 6 it is unknown if BMI at referral and prior to the onset of the eating disorder systematically deviates from population-based age and gender-matched controls. Accordingly, DSM-IV 7 cautiously states that 'individuals with BN typically are within the normal weight range, although some may be slightly underweight or overweight%.the disorder occurs but is uncommon among moderately and morbidly obese individuals%.there are suggestions that, prior to the onset of BN, individuals with this eating disorder are more likely to be overweight than their peers'. Nevertheless, obesity is perceived as a risk factor for the development of BN. 8 Hence, genotypes predisposing to obesity should have a greater frequency in BN patients than in population-based controls. Mutations in the melanocortin-4 receptor gene (MC4R) account for a clinically relevant percentage of obesity in humans; [9] [10] [11] [12] [13] [14] other monogenic forms of obesity are exceedingly rare. [15] [16] [17] [18] [19] [20] Five different haplo-insufficiency mutations in the MC4R have been reported. [9] [10] [11] [12] [13] [14] Approximately 1% of extremely obese German children and adolescents harbor such mutations. 13 In addition, with the exception of two polymorphisms several different missense mutations have been detected in extremely obese children, adolescents and adults, but not in normal or underweight controls. 11, 12, 14, 21, 22 The combined frequency of all nonsense, frameshift and missense mutations in these obese cohorts is in the magnitude of 2-4%. 11, 12, 14 Other lines of evidence also substantiate the relevance of these mutations for obesity: (a) Heterozygous MC4R knockout mice have a body weight intermediate between wild-type mice and homozygous knockouts. 23, 24 (b) A porcine MC4R missense mutation is associated with fatness. 25 (c) In humans, the mutations have mostly been shown to co-segregate with obesity within pedigrees. [9] [10] [11] [12] [13] [14] (c) Loss of function can be detected for the haplo-insufficiency mutations and the majority of the missense mutations. 11, 14, 26 The association of obesity and binge eating disorder (BED) is well established. 7 Previously, we identified an obese female with a MC4R haplo-insufficiency mutation who fulfilled lifetime criteria for BED, 13 marking the first observation of the co-occurrence of such a mutation and an eating disorder. Based on this finding and the postulated causal role of obesity in the development of BN we systematically performed a mutation screen in adolescent and adult BN patients for MC4R mutations.
Out of a total of 108 BN patients screened for MC4R mutations in this (n = 81) and our previous study (n = 27), 12 we identified a single extremely obese female with a functionally relevant mutation. This 32-year-old patient with both a nonsense (Tyr-35-Stop) and missense (Asp-37-Val) mutation, presumably constituting a haplotype, 12 ,13 had a current and maximal BMI of 48.0 and 51.1 kg m −2 , respectively. She was living alone and had a full-time job as a blue collar worker. She recalled being overweight ever since early childhood. Her lowest adult BMI was 26.7 kg m −2 at age 24, achieved upon dieting for almost one year resulting in a weight loss of 40 kg. First inpatient treatment for obesity was at age 14. Binge eating episodes (3-5 per day) commenced at age 27 and were frequently associated with ingestion of Ͼ5000 kcal. Intermittent dieting and self-induced vomiting occurred daily. She had been treated for BN both as an outpatient and inpatient. She reported being depressed for the past year. According to this female, eating was her sole strategy to solve her personal problems.
Four of the 81 BN patients in this study revealed the two distinct MC4R polymorphisms (Val-103-Ile; Ile-251-Leu), which are seemingly functionally irrelevant 11, 21 and have low frequencies in both obese and non-obese individuals. 11, 12, 14, 21, 22 None of the BN patients harbored functionally relevant MC4R missense mutations, which occur in approximately 1-3% of extremely obese probands. 27 This first observation of a mutation predisposing to obesity in a BN patient extends the link between the risk factor obesity and BN to the molecular level. It is trivial to point out that this finding by no means proves a statistical association between such mutations and BN. If we assume that 1% of BN patients and 0% of non-obese controls have such mutations, the study and the control groups would each have to encompass 615 probands in order to detect a significant association (PϽ0.05) with a power of 80%. We expect that BN patients with such mutations would also most likely be obese. However, in contrast to classical association studies which aim to statistically identify differences in allele frequencies between cases and controls in order to address potential functional implications, we have screened for mutations with an already known phenotypical effect.
Whereas the co-occurrence of obesity associated with MC4R haplo-insufficiency and BN in this single patient might be co-incidental, the case report makes a direct or indirect causal relationship appear highly likely. In the light of our previous observation of BED associated with MC4R haplo-insufficiency, 13 it appears possible that this genetic form of obesity directly predisposes to binge-eating episodes via eg increased hunger sensations. However, because approximately 30% of obese individuals in weight control programs have BED, 7 the observed co-occurrence of binge-eating episodes and MC4R mutations might represent an indirect link. Accordingly, the biologically driven urge to overeat might be etiologically less relevant than other mechanisms such as intermittent fasting, which in itself predisposes to binge eating. Indeed, in our patient with childhood onset obesity, BN did not set in until age 27 after significant diet-induced weight loss at age 24. BN might thus be viewed as a socio-culturally driven coping strategy in patients genetically predisposed to obesity.
Mean current and maximal BMIs of the 81 patients with BN were 23.5 ± 6.9 and 27.0 ± 8 kg m , respectively; mean current age and the mean recalled age at maximal BMI were 24.5 ± 6.9 and 20.7 ± 6.2 years, respectively. Sixteen and 44 out of the 81 patients had current BMI Ն 90th and Ն 50th centile, respectively (mean centile: 54.3 ± 34.0; Figure 1a,b) . In contrast, among the 75 patients who recalled both maximal weight and the corresponding age, 39 and 67 had maximal BMI Ն 90th and Ն 50th centile, respectively (mean centile: 81.9 ± 21.8). Seventeen patients fulfilled the WHO criteria 28 for current overweight (BMI Ն 25 kg m −2 ) and 10 patients of this subgroup also fulfilled the criterion for obesity (BMI Ն 30 kg m
−2
). Maximal BMI were Ն 25 and Ն 30 kg m −2 in 34 and 13 patients, respectively.
Because BN is typically a disorder of late adolescence and early adulthood-only seven of our patients were older than 35 years-the WHO cutoffs for adult overweight and obesity must be viewed with caution in young study groups. Thus, BMI age centiles provide a better method of assessing the relative weight of patients with eating disorders. 6 Because the BMI centiles used in this study were calculated from selfreported anthropometric measurements obtained within the German National Nutrition Survey between 1985 and 1989, particularly the 90th centile can be expected to be somewhat higher in today's general population than illustrated in Figure 1 .
The fact that the current mean BMI centile of our patients is only slightly above the 50th centile suggests that most females seeking inpatient treatment for BN have a BMI distribution, that does not substantially deviate from the expected distribution. However, four of the 81 patients had a current BMI Ն 40 kg m −2 , which is clearly more than can be expected on a population based level and is also in agreement with other studies demonstrating the occurrence of extreme obesity in single BN patients. [1] [2] [3] [4] Vice versa, extremely obese patients have only infrequently been screened for BN. According to a previous study of ours, three out of 47 extremely obese adolescents and young adults qualified for a lifetime diagnosis of BN. 29 Our data clearly substantiate that the lifetime occurrence of overweight is common in inpatients treated for BN, if these females do not overestimate their maximal weight. Potentially, the development of a severe form of BN might frequently result in weight loss, indicating that the counter-regulation is 'successful'. Because we have no population based data on maximal BMI, the assessment of the patients' lifetime data could only be performed upon use of population-based current BMI. Obviously, this procedure must be viewed critically: the rate of lifetime overweight in patients with BN would not be as substantial as suggested in Figure 1 , if a comparison to lifetime maximal population-based BMI would have been possible. Additionally, due to the ascertainment for a molecular genetic study of BN we cannot exclude that patients with lifetime occurrence of overweight preferentially participated. Furthermore, because the Klinik Roseneck represents a tertiary treatment center, BN patients with a history of overweight might represent a more severely ill group.
In spite of these reservations it is of interest to point ) of patients with bulimia nervosa plotted into percentiles representative for German females. 6 For current and maximal BMI, exact age and age in years, respectively, were available. Gene variant carriers are symbolized by filled-in circles; the effect of the nonsense (Try-35-Stop) and missense mutations on the amino acid sequence is indicated.
out that the patients' mean age and current BMI are remarkably similar to those of the 102 females with BN (23.9 ± 5.0; 24.4 ± 4.8 kg m −2 ) recruited in the epidemiological study of Fairburn and coworkers. 30 Furthermore, the frequent occurrence of lifetime overweight is also compatible with the studies of Fairburn et al. 8, 30, 31 Because these investigators have shown that parental obesity occurs more commonly among females with BN than in controls, 8 it seems highly probable that a substantial percentage of patients has a genetic predisposition to develop overweight. Thus, the elevated rates of overweight and obesity seemingly cannot be explained as a consequence of BN.
We conclude that overweight is most likely a risk factor for the development of BN not only in epidemiologically ascertained females with BN 8 but also in a substantial subgroup of females with BN who present for inpatient treatment. Further research is definitely required to more systematically address the relation-
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ship between BN and overweight. Based on the first detection of a mutation predisposing to obesity in a BN patient, we predict that other genotypes relevant for obesity will also be found in these patients. These genotypes might directly predispose to binge eating especially if the mutation is associated with an increased energy intake (overeating), as has been shown in studies of MC4R knockout mice. 23, 24 Alternatively, the mutation predisposes primarily to obesity, which in modern societies is the relevant mediator for development of aberrant eating behavior and in clinical terms BED or BN.
Materials and methods
The 81 female inpatients with BN were ascertained at the Klinik Roseneck in Prien (n = 73) and the Department of Child and Adolescent Psychiatry of the University of Marburg (n = 8). All patients gave written infor-med consent; the study was approved by the Ethics Committee of the University of Marburg. BN of the purging type was the clinical diagnosis for all patients, who additionally fulfilled the DSM-IV criteria for this type of BN as based on the eating disorders module of the M-Composite International Diagnostic Interview. 32 Patients' current weights and heights were measured at the time of the interview. Seventy-five of the patients recalled their maximal weight and the corresponding age. Maximal BMI was calculated from recalled maximal weight and measured current body height (see Coners et al for the potentially small error introduced by this approach). 33 All patients were additionally interviewed with a semi-structured interview to allow determination of weight and medical histories. Both current and maximal BMI were plotted into BMI centiles representative of the female German population as determined in the German National Nutrition Survey. 6 Centiles were calculated using quantile regression. 34 We screened the 81 patients with BN by single strand conformation analysis (SSCA). Subsequently, bi-directional sequencing of PCR products showing an aberrant SSCA pattern was performed as described previously. 12 
